健康英语新闻:Study shows early treatment with antiretroviral therapy prevents HIV transmission
The results also demonstrated a clinical benefit of early ART, especially in the prevention of a type of tuberculosis infection outside the lungs (extrapulmonary tuberculosis).
"We want to thank the study participants for making such an important contribution in the fight against HIV/AIDS. We think that these results will be important to help improve both HIV treatment and prevention," Cohen said in a statement.
study participants are being informed of the results, and HIV- infected individuals in the delayed treatment arm are being offered ART. The study investigators will continue to monitor participants for at least one more year.
The research was conducted by the HIV Prevention Trials Network, which is largely funded by the U.S. National Institute of Allergy and Infectious Diseases.
"Previous data about the potential value of antiretrovirals in making HIV-infected individuals less infectious to their sexual partners came largely from observational and epidemiological studies," said NIAID Director Anthony S. Fauci in a statement. " This new finding convincingly demonstrates that treating the infected individual -- and doing so sooner rather than later -- can have a major impact on reducing HIV transmission."
相关文章
- 英语文摘:China urges G7 to cease interfering in its internal affairs
- 英语文摘:HKSAR gov't strongly refutes G7, EU statements on chief executive election
- 英语文摘:Xi's keynote speech at opening ceremony of Boao Forum for Asia Annual Conference 2022 publ
- 英语文摘:Xi attends ceremony marking centenary of Communist Youth League of China
- 英语文摘:Xi talks with Macron over phone
- 英语文摘:External interference in Hong Kong affairs doomed to be self-defeating: Commissioner's off
- 英语文摘:Chinese spokesperson slams Western countries smearing Hong Kong election
- 英语文摘:China calls for equal, balanced global development partnership
- 英语文摘:Xinhua Headlines: A look at younger generation on China's new journey
- 英语文摘:Chinese vice premier reiterates dynamic zero-COVID policy